Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Clinical trial NCT05205200 · UNKNOWN
Trial details
- NCT number
- NCT05205200
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2025-02-01
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.